The effectiveness of acceptance and commitment based therapy (ACT) on quality of life in patients who live with maintenance dialysis.

The effectiveness of acceptance and commitment based therapy on some mental health indices and quality of life in patients who live with maintenance dialysis.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016082729551N1

Enrollment

Registered

2017-01-01

Start date

2016-12-09

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease. Chronic kidney disease, stage 5

Interventions

Intervention 1: The second group will receive cognitive behavioral therapy in 8 session. they will continue their previous medications. Intervention 2: The third group is, control group. They will not

Lifestyle

Treatment - Drugs

The second group will receive cognitive behavioral therapy in 8 session. they will continue their previous medications.

The third group is, control group. They will not receive psychological treatment. They just will take their previous medications.

The first group is the ACT group. they will experience acceptance and commitment based therapy in 8 Sessions.Their previous medications will continue as before.

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Participants must have end stage renal failure treated with maintenance dialysis. Minimum education that is considering is elementary and also participants should not have experience of being treated with acceptance and commitment based therapy .Also, Individuals should not have a history of substance abuse, psychotic disorders and mental retardation .Exclusion criteria :acute or chronic physical illness that cause hardships to endure long meetings. Severe side effects of kidney failure requiring hospitalization or surgery. Report of having any mental disorder (eg, psychosis) that need to be hospitalized. Psychotropic drugs or substance abuse currently. And finally absence of more than three sessions of therapy.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Quality Of Life. Timepoint: pretest before the inervention, post test after the intervention and follow up after 2 month. Method of measurement: Kidney Disease Quality of Life – Short Form version 1.3 for use with Iranian patients.	—

Secondary

Measure	Time frame
Depression. Timepoint: pretest before the intervention, post test after the intervention and follow up 2 month later. Method of measurement: Hospital Anxiety and Depression Scale.;Anxiety. Timepoint: pretest before the intervention, post test after the intervention and follow up 2 month later. Method of measurement: Hospital Anxiety and Depression Scale.;Mental health. Timepoint: pretest before the intervention, post test after the intervention and follow up 2 month later. Method of measurement: Hospital Anxiety and Depression Scale Kidney Disease Quality of Life – Short Form.	—

Measure

Time frame

Depression. Timepoint: pretest before the intervention, post test after the intervention and follow up 2 month later. Method of measurement: Hospital Anxiety and Depression Scale.;Anxiety. Timepoint: pretest before the intervention, post test after the intervention and follow up 2 month later. Method of measurement: Hospital Anxiety and Depression Scale.;Mental health. Timepoint: pretest before the intervention, post test after the intervention and follow up 2 month later. Method of measurement: Hospital Anxiety and Depression Scale Kidney Disease Quality of Life – Short Form.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMonireh Nazari

Shahid Beheshti University Of Medical Sciences

m_nazari@sbmu.ac.ir+98 21 2303 1548

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026